Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06VYE
|
||||
| Former ID |
DNAP001340
|
||||
| Drug Name |
Belotecan hydrocholoride
|
||||
| Indication | Small-cell lung cancer [ICD9: 162.9; ICD10:C33-C34] | Approved | [551871] | ||
| Target and Pathway | |||||
| Target(s) | DNA topoisomerase I | Target Info | Modulator | [529023], [530110] | |
| WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
| References | |||||
| Ref 529023 | Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study. Ann Oncol. 2008 Jan;19(1):123-7. Epub 2007 Sep 6. | ||||
| Ref 530110 | Impact of natural products on developing new anti-cancer agents. Chem Rev. 2009 Jul;109(7):3012-43. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.